Xanthine oxidase inhibition for the improvement of long-term outcomes following ischaemic stroke and transient ischaemic attack (XILO-FIST) – Protocol for a randomised double blind placebo-controlled clinical trial

BACKGROUND: Allopurinol, a xanthine oxidase inhibitor, reduced progression of carotid-intima media thickness and lowered blood pressure in a small clinical trial in people with ischaemic stroke. Xanthine oxidase inhibition for improvement of long-term outcomes following ischaemic stroke and transien...

Descripción completa

Detalles Bibliográficos
Autores principales: Dawson, Jesse, Broomfield, Niall, Dani, Krishna, Dickie, David A, Doney, Alex, Forbes, Kirsten, Houston, Graeme, Kean, Sharon, Lees, Kennedy, McConnachie, Alex, Muir, Keith W, Quinn, Terry, Struthers, Allan, Walters, Matthew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6120121/
https://www.ncbi.nlm.nih.gov/pubmed/30246149
http://dx.doi.org/10.1177/2396987318771426

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6120121/
https://www.ncbi.nlm.nih.gov/pubmed/30246149
http://dx.doi.org/10.1177/2396987318771426

Ejemplares similares